Short answer
Mineralys Therapeutics, Inc. (MLYS) filed an 8-K current report with the SEC on May 22, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Three Class III directors elected for terms expiring at the 2029 annual meeting.
Mineralys Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Three Class III directors elected for terms expiring at the 2029 annual meeting
- Daphne Karydas received 66,626,766 votes, versus 40,667,555 for Srinivas Akkaraju and 42,487,140 for Brian Slingsby
- Ernst & Young LLP ratified as independent auditor for fiscal year 2026 with 72,648,272 votes
- Both proposals approved, preserving board continuity and auditor appointment through the 2026 fiscal year
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Mineralys Therapeutics, Inc. 8-K filings
Get the next MLYS 8-K as it lands
Follow MLYS for push alerts, or ask the research agent what this filing means.